N-benzyl-D-glucamine dithiocarbamate (BG.DTC) and its analog, N-(4-methoxybenzyl)-D-glucamine dithiocarba mate (MeO-BG.DTC) which are effective chelators of cadmium were investigated for their efficacy to induce excretion of lead, to reduce tissue burden of lead and to reverse certain lead sensitive biochemical alterations in lead pre-exposed rats. These were quite effective in reducing hepatic and renal but not brain lead levels as reflected by the enhanced urinary and fecal excretion of lead and in partially restoring lead inhibited blood delta- aminolevulinic acid dehydratase activity. The introduc tion of a methoxy group at para-position of benzyl ring, unlike in case of cadmium, did not improve the lead chelating ability of the compound. The treatment with BG.DTC and MeO-BG. DTC caused depletion of endogen ous essential elements such as zinc, copper and calcium as evidenced by their enhanced excretion and decreased tissue contents which were more marked in animals treated with the latter.
Kojima S. et al. Studies on poisonous metals XVIII. Effects of several dithiocarbamates on tissue distribution and excretion of cadmium in rats. Chem. Pharm. Bulletin (Tokyo) 1987; 35: 3838-3844.
2.
Jones MMNew developments in therapeutic chelating agents as antidotes for metal poisoning . Critical Review in Toxicology1991; 21: 209-233.
3.
Tandon SK, Hashmi NS, Kachru DNChelation in Metal Intoxication XXXII: The lead-chelating effects of dithiocarbamates. Biomedical EnvironmentalSciences1990; 3: 299-305.
4.
Tandon SK, Kachru DNChelation in metal intoxication XXXVI: Effect of substituted piperazine dithiocarbamates in lead-exposed rats. Acta Pharmacologica Sinica1991; 12: 391- 394.
5.
Kojima S., Kaminaka K., Kiyozumi M., Honda T.Comparative effects of three chelating agents on distribution and excretion of cadmium in rats. Toxicology Applied Pharmacology1986; 83: 516-524.
6.
Jones SG, Singh PK, Jones MMUse of the topliss scheme for the design of more effective chelating agents for cadmium decarporation. Chemical Research in Toxicology1988; 1: 234-237.
7.
Gale GR et al. N, N-Disubstituted dithiocarbamates as cadmium antagonists; N-(4-methoxybenzyl)-N-dithiocarboxy-D-glucamine. Toxicology Letters1989; 48: 105-115.
8.
Kachru DN, Singh S., Tandon SKChelation in metal intoxication XXXIV: Mixed ligand chelation in lead poisoning . Toxicology Letters1991; 57, 251-256.
9.
Berlin A., Schaller KHEuropean standardized method for determination of delta-aminolevulinic acid dehydratase activity in blood. Zeitskrift Klinical Chemistry Klinical Biochemistry1974; 12: 389-390.
10.
Davis JR, Abrahams RH, Fishbein WJ, Fabrega EAUrinary delta-aminolevulinic acid (ALA) levels in lead poisoning II. Correlation of ALA values with clinical findings in 250 children with suspected lead ingestion. ArchiveEnvironmental Health1968; 17: 164-171.
11.
Yeager DW, Cholak J., Henderson EWDetermination of lead in biological and related material by atomic absorption spectrometry. Environmental Science Technology1971; 5: 1020-1022.
12.
Parker MN, Humoller FL, Mahler DJDetermination of copper and zinc in biological material. Clinical Chemistry1967; 13: 40-48.
Cory-Slechta DA, Weiss B., Cox C.Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate therapy . Journal of Pharmacology Experimental Therapeutics1987; 243: 804-813.
15.
Fowler BA, Duval G.Effects of lead on the kidney: Roles of high-affinity lead-binding proteins. Environ mental HealthPerspectives1991; 91: 77-80.
16.
Mistry P., Mastri C., Fowler BAInfluence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney. Biochemical Pharmacology1986; 35: 711-713.
17.
DuVal GE, Fowler BAPreliminary purification and characterisation studies of a low-molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochemical Biophysics ResearchCommunication1989; 159: 177-184.
